Prior to the XF Extracellular Analyzer, scientists relied on 50 year old Clark electrode technology for measuring cell metabolism, a time-consuming technique that provides nominal basic information. Now in minutes, the XF Analyzer measures oxygen consumption--an indicator of mitochondrial respiration--as well as extracellular acidification, a product of glycolysis (sugar burning). With just a small number of cells, investigators can measure the effects of up to four compounds on cellular metabolism, determining the basal oxygen consumption and glycolysis rates; respiratory capacity; mitochondrial dysfunction; fatty acid oxidation, glucose, fatty acid, and amino acid metabolism; uncoupling; ATP turnover; and cell signaling in primary, adherent, tumor and suspension cells, islets, and isolated mitochondria. All important information needed when developing new drugs.
One of TheScientist's judge's Dr. H. Steven Wiley, summed up the XF Analyzer's significance stating: "I want one!'
About Seahorse Bioscience
SEAHORSE XF ANALYZERS have become the new standard in cellular bioenergetic measurements. Scientists worldwide use these tools to advance their research in understanding the role of mitochondrial function in obesity, diabetes, ageing, cancer, cardiovascular function and safety toxicity. Founded in 2001, Seahorse headquarters are in North Billerica, MA. For more information, please visit http://www.seahorsebio.com.
Media Contact: Cynthia Egan Phone: 978.671.1610
SOURCE Seahorse Bioscience, Inc.
|SOURCE Seahorse Bioscience, Inc.|
Copyright©2009 PR Newswire.
All rights reserved